Opaganib

N/A

Report date: 2022/08/08 13:38:53
NME

Base Information

Drug NameOpaganib
Drug Alias NameYelivaABC-294640
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine kinase 2 inhibitors
TargetsSphingosine kinase 2
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Solid tumoursLung Diseases +[11
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandMexico +[10
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesApogee Biotechnology Co
Active IndicationsCoronavirus Disease 2019 (COVID-19)Lung DiseasesProstatic Neoplasms +[5
Inactive IndicationsSolid tumoursPancreatic NeoplasmsMultiple Myeloma +[6

Other Information

ATC CodeN/A
Related LinksWikipedia